MellingMedical and CellTivity Scientific Team Up to Enhance Diagnostic Cancer Sampling for Federal Healthcare Providers

Cutting edge cellular imaging expands real-time biopsy assessment capabilities for veterans, active duty and DoD clinicians.

ALEXANDRIA, Va., Nov. 11, 2026 /PRNewswire/ -- MellingMedical today announced a new strategic relationship with CellTivity Scientific, an innovative leader in point-of-care disease detection and cellular imaging solutions. As part of its new relationship, Alexandria-based MellingMedical will leverage its status as an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB) to bring CellTivity's Van Gogh® Microscopy System to federal healthcare providers serving America's veterans, active-duty military personnel and their families.

"CellTivity's track record of engineering high-quality, innovative diagnostic workflow solutions makes them an ideal ally for serving federal healthcare providers," said Chris Melling, founder and CEO of MellingMedical. "Their specialized focus on cutting-edge technologies like the Van Gogh system will provide federal healthcare clinicians with the tools they need to enhance diagnostic confidence, maximize tissue sufficiency for next-generation sequencing, and deliver timely, optimal patient care."

PATHWAY TO AVAILABILITY
The arrangement makes CellTivity's Van Gogh Microscopy System immediately available to veterans through MellingMedical's federal contracting network. The Waltham, Massachusetts-based company's mission to eliminate the uncertainty, inaccuracy, and delay of biopsy assessment aligns perfectly with federal sourcing priorities aimed at improving patient outcomes.

CUTTING EDGE TECHNOLOGY
The agreement encompasses CellTivity's Van Gogh Microscopy System, an FDA Class I in-vitro diagnostic medical device powered by Dynamic Cell Imaging™ (DCI). This groundbreaking technology allows proceduralists to assess freshly excised biopsies in real time—akin to a tissue-based PET scan—digitally measuring intracellular and metabolic activity up to 150µm below the tissue surface. This process requires no cutting or staining, leaving 100% of the sample unchanged and perfectly preserved for definitive pathology and downstream molecular analysis.

Greg Bowles, CEO of CellTivity Scientific, added: "We are excited to align with MellingMedical to expand access to our advanced cellular imaging solutions throughout the federal healthcare system. Our shared commitment to providing premium-quality medical devices makes this collaboration particularly meaningful for advancing care for those who serve our country."

UNDERSTANDING THE MARKETPLACE
The federal healthcare marketplace is the largest integrated medical system in the United States, presenting a vast and dynamic opportunity for innovative companies like CellTivity Scientific. Under the current administration and Veterans Administration leadership, this landscape is undergoing an exciting, modernization-focused transformation designed to cut bureaucratic red tape, streamline procurement, and prioritize high-value, efficient care. Rather than creating new hurdles, these sweeping reforms actually represent unprecedented opportunities for agile, compliant organizations to excel and stand out. By collaborating with MellingMedical, CellTivity gains a strategic guide uniquely equipped to harness this new momentum. This alliance compresses the timeline for market entry by leveraging MellingMedical's established SDVOSB contract infrastructure and proven regulatory expertise, ensuring CellTivity's state-of-the-art cellular imaging solutions reach federal patients faster and more efficiently than ever before.

A COMMITMENT TO SERVICE
In conclusion, Chris Melling said, "No matter how innovative a medical products company might be, they still need to get their technology to the patient. As the federal government continues its efforts to reform the care offered through its healthcare system, suppliers like CellTivity can get their state-of-the-art platform to clinicians faster by working with MellingMedical, bringing to bear the high-value outcomes our veterans have earned."

About MellingMedical
MellingMedical, an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), holds a Medical Equipment and Surgical Federal Supply Schedule (Med/Surg), as well as a Pharmaceutical Schedule and ECAT capabilities, providing innovative and cost-effective healthcare solutions to all 172 VA Medical Centers and 1,138 VA Outpatient Clinics, all seven (7) VA CMOPs, 95 DoD Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). To learn more, visit MellingMedical.com.

About CellTivity
Headquartered in Waltham, MA, CellTivity Scientific is a medical technology company advancing real-time cellular imaging solutions designed to enhance diagnostic confidence and procedural precision. The company's Van Gogh Microscopy System empowers proceduralists by disrupting the traditional process of diagnosing cancer, providing digital measurement of intracellular and metabolic activity throughout extracted tissue. This supports intraprocedural tissue assessment, helping clinicians make more informed decisions at the point of care while preserving tissue for final pathology. To learn more, visit www.celltivity.com.

SOURCE MellingMedical